Human immunodeficiency virus inhibitor (HIVI) was developed by the Terminus Disease Research Center in 1988 after experimentation on sims. The HIVI supressed the effects of HIV, bolstering the immune system of an infected individual. It did not act as a cure, however, and an individual could still infect others with HIV.